Home > Drug Search >
  • company_query: Advanced Accelerator Applications
  •   > 
Drug Filter
Category:
chemistry (13) biology (25)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (15) Phase Ⅰ (15)
Clinical Stage:
Pending (8) Active (21) Discontinued (7)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (19) Recombinant enzyme (2) Other recombinant protein (1)
Indication:
Atopic dermatitis (1) Breast cancer (1) Colorectal neoplasms (1) Dry eye disease (1) Endometrial cancer (1) HCV infection (2) Melanoma (3) Metastatic breast cancer (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (2) Ovarian cancer (1) Pancreatic cancer (1) Postmenopausal osteoporosis (1) Prostate cancer (3) Psoriasis (1) Rheumatoid arthritis (RA) (2) Secondary hyperparathyroidism (HPT) (1) Small cell lung cancer (SCLC) (1) Smoking cessation (2) Solid tumours (2) Rotavirus infection (1) Typhoid (2) Acute intermittent porphyria (1) Retinal dystrophies (1) Carotid stenosis (1) Colorectal cancer (1) Dysentery (1) Ankylosing Spondylitis (AS) (1) Sarcoma (1) Diagnostic agents (2) Hypertrophic cardiomyopathy (1) Cardiomyopathy (1) Glioblastoma (1) Graft versus host disease (1) Respiratory syncytial virus infection (1) Mesothelioma (2) Liver cancer (1) hematological malignancies (1) Scleroderma (1) Ocular inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top